HIND ReShape Lifesciences: Earnings per share for the last twelve months

Vyome Holdings Inc generates revenue through the sale of Lap-Band systems and the development of weight-loss medications. The 12-month net income per share snapshot provided by the GURU.Markets portal shows a value of -0.57 as the current metric. However, the risk of clinical trial failure and the costs of immunological research, coupled with a lack of stable cash flow, create financial vulnerability.
Analytical breakdowns and data insights for company Vyome Holdings Inc (HIND)

The efficiency of Vyome Holdings Inc (HIND) R&D spending on obesity treatment is directly reflected in the earnings per share trend. This metric aggregates net income over four quarters, dividing it by the total number of outstanding shares. By analyzing the trailing twelve-month net income per share, an investor determines the business's specific profitability. Stable value ranges confirm margin resilience, while peak figures often signal the risk of a subsequent correction.